Safety and efficacy of durvalumab after concurrent chemoradiation in Black patients with locally advanced non-small cell lung cancer.
Neal S McCallJames R Janopaul-NaylorH Scott McGinnisAparna H KesarwalaSibo TianWilliam A StokesJoseph W SheltonConor E SteuerJennifer Wilkinson CarlisleTiciana A LealSuresh R RamalingamJeffrey D BradleyKristin A HigginsPublished in: Cancer (2023)
The efficacy and tolerability of consolidative durvalumab after chemoradiation appears to be comparable between Black and non-Black patients.